Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

GG Schwartz, AG Olsson, MD Ezekowitz, P Ganz… - Jama, 2001 - jamanetwork.com
ContextPatients experience the highest rate of death and recurrent ischemic events during
the early period after an acute coronary syndrome, but it is not known whether early initiation …

Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials.

PJ de Feyter, PW Serruys, MJ Davies, P Richardson… - Circulation, 1991 - Am Heart Assoc
T here have been five primary prevention trials of which the purpose was to determine
whether reducing hypercholesterolemia would also decrease the incidence of coronary …

Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene

RA Riemersma, DA Wood, MF Oliver, RA Elton… - The Lancet, 1991 - Elsevier
The relation between risk of angina pectoris and plasma concentrations of vitamins A, C,
and E and carotene was examined in a population case-control study of 110 cases of …

Might treatment of hypercholesterolaemia increase non-cardiac mortality?

MF Oliver - The Lancet, 1991 - elibrary.ru
Offers a viewpoint that states that available data indicates that total mortality is unchanged
when hypercholesterolemia is lowered and the fall in cardiac mortality is offset by an …

Relation between serum-free-fatty-acids and arrhythmias and death after acute myocardial infarction

MF Oliver, VA Kurien, TW Greenwood - The Lancet, 1968 - Elsevier
Abstract Serum-free-fatty-acid (FFA) levels measured in 200 patients during the first forty-
eight hours after an acute myocardial infarction have been related to the prevalence of …

Relation of plaque lipid composition and morphology to the stability of human aortic plaques

CV Felton, D Crook, MJ Davies… - … , thrombosis, and vascular …, 1997 - Am Heart Assoc
The propensity of atherosclerotic plaques to disrupt may be influenced by their lipid content
and the distribution of these lipids within the plaque. To investigate this, we analyzed the …

Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes

MF Oliver - The American journal of medicine, 2002 - Elsevier
The mechanisms leading to ventricular fibrillation that occur during acute myocardial
ischemia are ill understood. Whether primary ventricular fibrillation is due to a transient …

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

AG Olsson, GG Schwartz, M Szarek… - European heart …, 2005 - academic.oup.com
Aims Patients with acute coronary syndrome (ACS) in the Myocardial Ischaemia Reduction
with Aggressive Cholesterol Lowering (MIRACL) study had diminished cardiovascular …

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT)

MF Oliver, L Goldman, DG Julian, I Holme… - The Journal of the …, 1999 - pubs.asahq.org
Background Mivazerol is a drug with alpha2-agonist properties that reduces post-ganglionic
noradrenaline availability and spinal efferent sympathetic output. Methods A double-blind …

Initial metabolic and hormonal response to acute myocardial infarction

NJ Vetter, W Adams, RC Strange, MF Oliver - The Lancet, 1974 - Elsevier
Plasma-concentrations of certain substrates and hormones were measured serially and
hourly from 1 to 5 hours after the onset of major symptoms in sixteen patients with acute …